Antidepressants and Pregnancy: Continued Evidence of Harm—Still No Evidence of Benefit
Abstract:Antidepressant medication use during pregnancy is increasing. It is essential that women of childbearing age, pregnant women, and their health care providers be aware of the risks, benefits, and alternatives prior to taking these agents. The best available evidence suggests that antidepressant use by pregnant women may be associated with miscarriage, birth defects, preterm birth, decreased birth weight, neonatal behavioral syndrome, persistent pulmonary hypertension in the newborn, neonatal electrocardiogram (EKG) changes, and behavioral effects. Evidence of benefit is lacking. The hope that improved maternal mood through medication would lead to better pregnancy results has not been realized; the antidepressant-exposed pregnancies are faring worse. The available evidence raises the question: Are we exposing a generation of women and their babies to drugs that are causing significantly more harm than good?
Document Type: Research Article
Publication date: 2011-12-01
More about this publication?
- Ethical Human Psychology and Psychiatry seeks to raise the level of scientific knowledge and ethical discourse, while empowering professionals who are devoted to principled human sciences and services unsullied by professional and economic interests.
- Information for Authors
- Membership Information
- Information for Advertisers
- Free Sample Issue
- Subscribe to this Journal
- Ingenta Connect is not responsible for the content or availability of external websites